| Literature DB >> 15695147 |
Silja K Majahalme1, Lawrence Baruch, Nora Aknay, Liselotte Goedel-Meinen, Monika Hofmann, Allen Hester, Margaret Forney Prescott, Nancy Feliciano.
Abstract
The comparison of treatment effect and co-morbidity between the genders in the Valsartan Heart Failure Trial showed equal benefit of treatment in men and women. Co-morbidities, such as diabetes and coronary artery disease, increased nonfatal cardiac morbidity more in women than in men.Entities:
Mesh：
Substances：
Year: 2005 PMID： 15695147 DOI： 10.1016/j.amjcard.2004.10.026
Source DB: PubMed Journal: Am J Cardiol ISSN： 0002-9149 Impact factor: 2.778